# AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

> **NCT04432220** · PHASE4 · RECRUITING · sponsor: **Yonsei University** · enrollment: 840 (estimated)

## Conditions studied

- Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation

## Interventions

- **DRUG:** Anticoagulation group(Apixaban group)

## Key facts

- **NCT ID:** NCT04432220
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-28
- **Primary completion:** 2026-07
- **Final completion:** 2028-10
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432220, "AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04432220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*